Study reveals increased risk of posthepatectomy portal vein thrombosis in cirrhotic patients using nonselective beta-blockers, suggesting hemodynamic impacts.
Background: Posthepatectomy portal vein thrombosis (PH-PVT) is a rare but serious complication after liver resection, especially in cirrhotic patients. Nonselective beta-blockers (NSBBs), commonly used to manage portal hypertension, may increase PH-PVT risk due to their hemodynamic effects.
No takes yet. Share an insight, caveat, or question.
Abdelhadi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: